Lv65
2500 积分 2023-03-05 加入
癌症晚期患者终末意愿依从性的研究进展
27天前
已关闭
肝细胞癌术后预防复发的研究进展
27天前
已完结
[Analysis of global liver cancer statistics]
27天前
已完结
2013年及2023年前后十年初诊肝细胞癌患者的临床特征变化及分析
27天前
已完结
HPLC-MS/MS determination and pharmacokinetic study of propofol in human plasma
29天前
已关闭
An analysis of the annual expenditure per liver cancer patient in China: from the perspective of the whole disease course
1个月前
已完结
Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis
1个月前
已完结
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial
1个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
1个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
